文献
J-GLOBAL ID:201702247462054984
整理番号:17A1707032
アテローム性動脈硬化症患者における入射肺癌に対するカナキヌマブによるインターロイキン-1β阻害の影響:無作為化,二重盲検,プラセボ対照試験からの予備的結果【Powered by NICT】
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
著者 (9件):
Ridker Paul M
(Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
,
Ridker Paul M
(Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
,
MacFadyen Jean G
(Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
,
Thuren Tom
(Novartis Pharmaceuticals, East Hanover, NJ, USA)
,
Thuren Tom
(Novartis Pharmaceuticals, Basel, Switzerland)
,
Everett Brendan M
(Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
,
Everett Brendan M
(Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
,
Libby Peter
(Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
,
Glynn Robert J
(Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
資料名:
Lancet
(Lancet)
巻:
390
号:
10105
ページ:
1833-1842
発行年:
2017年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)